Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Reversible disconnection syndrome in a case of acute tumefactive demyelinating lesion: a PET study.
A Hedonism Hub in the Human Brain.
Differential Effects of Stress on Microglial Cell Activation in Male and Female Medial Prefrontal Cortex.
Multiple sclerosis animal models: A clinical and histopathological perspective.
Genetics of rat neuroinflammation.
Distinct origins, gene expression and function of microglia and monocyte-derived macrophages in CNS myelin injury and regeneration.
Multifocal enlargement and increased vascularization of peripheral nerves detected by sonography in CIDP: A pilot study.
Auditory information processing in rat genotypes with different dopaminergic properties.
Calpain Inhibition Reduces Structural and Functional Impairment of Retinal Ganglion Cells in Experimental Optic Neuritis.
How human IgGs against DNA recognize oligonucleotides and DNA.
Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica.
Symptomatic treatment in multiple sclerosis-interim analysis of a nationwide registry.
A Microsoft Kinect-Based Point-of-Care Gait Assessment Framework for Multiple Sclerosis Patients.
Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires.
A Clinical Decision Support System with an Integrated EMR for Diagnosis of Peripheral Neuropathy.
Opposing Roles of Interferon-Gamma on Cells of the Central Nervous System in Autoimmune Neuroinflammation.
Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients.
The urinary-specific quality of life of multiple sclerosis patients: Dutch translation and validation of the SF-Qualiveen.
Rapid measurement of brain macromolecular proton fraction with transient saturation transfer MRI.
Combination treatment of fingolimod with antidepressants in relapsing-remitting multiple sclerosis patients with depression: a multicentre, open-label study - REGAIN.
The regulator's perspective: How should new therapies and follow-on products for MS be clinically evaluated in the future?
Neurologic Diseases in Special Care Patients.
Thermal patterns in zoster.
The Corpus Callosum and Forensic Issues-An Overview.
Clusterin CSF levels in differential diagnosis of neurodegenerative disorders.

Pages